Outspoken Oncology

Chadi Nabhan makes his rounds at the European Hematology Association Annual Meeting and the International Conference on Malignant Lymphoma, interviewing guests such as Elias Jabbour, Kim Linton, and Stefano Luminari.

Vinay Prasad, MD, MPH, policy research and oncologist, dissects with Chadi the theory of "value-based care." How can this concept be used as a tool to better patient care and lower the cost of cancer therapies? Are current value estimations useful in this space?

Dr Prasad's podcast "Plenary Session" can be found at vinayakkprasad.com/plenarysession.

Vinay Prasad, MD, MPH, policy research and oncologist, dissects with Chadi the theory of "value-based care." How can this concept be used as a tool to better patient care and lower the cost of cancer therapies? Are current value estimations useful in this space?

Dr Prasad's podcast "Plenary Session" can be found at vinayakkprasad.com/plenarysession.

Patients and their treating oncologists are faced with many challenges today, including rising drug prices and the opioid crisis, as well as clinical pathway optimization and algorithms to furthering community oncology engagement in clinical research. To discuss it all, Chadi sat down with Clifford Hudis, MD, FACP, FASCO, chief executive officer of ASCO, at the recent ASCO annual meeting. In this one-on-one interview, Dr Hudis shares his views and describes how ASCO is working to optimize care delivery for patients amid these challenges in oncology care.

Patients and their treating oncologists are faced with many challenges today, including rising drug prices and the opioid crisis, as well as clinical pathway optimization and algorithms to furthering community oncology engagement in clinical research. To discuss it all, Chadi sat down with Clifford Hudis, MD, FACP, FASCO, chief executive officer of ASCO, at the recent ASCO annual meeting. In this one-on-one interview, Dr Hudis shares his views and describes how ASCO is working to optimize care delivery for patients amid these challenges in oncology care.

Bishal Gyawali, MD, PhD, global oncologist and policy researcher, explains to Chadi the financial toxicity faced by patients with cancer and potential strategies to mitigate it. What can be done to “avoid wisely” low-value practices?

Bishal Gyawali, MD, PhD, global oncologist and policy researcher, explains to Chadi the financial toxicity faced by patients with cancer and potential strategies to mitigate it. What can be done to “avoid wisely” low-value practices?

Eric Topol, MD, a cardiologist, best-selling author, and entrepreneur, sits down with Chadi to discuss how AI can impact current and future patient care. Chadi explores various aspects of Topol’s recent book, “Deep Medicine,” which comprehensively evaluates the pros and cons of AI in health care.

Eric Topol, MD, a cardiologist, best-selling author, and entrepreneur, sits down with Chadi to discuss how AI can impact current and future patient care. Chadi explores various aspects of Topol’s recent book, “Deep Medicine,” which comprehensively evaluates the pros and cons of AI in health care.

Chadi sits down with Alison Bateman-House, PhD, MPH, MA, to discuss the details of the Right To Try Act a year after it was signed into law. Was it a good idea? Do patients stand to benefit? What led to this initiative and how does this help clinical trial enrollment, if at all?